Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell), covering 2023-04-19 to 2023-04-19. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 [Phase 1, Phase 2]